| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA620363 | F | Inhibitory concentration against 8226 myeloma cancer cell line | Homo sapiens | 4 | cell-based format | Scientific Literature | ||
| 2. | ALA620364 | F | Inhibitory concentration against 8226/Dox40 (Dox-Re) cancer cell line | Homo sapiens | 4 | cell-based format | Scientific Literature | ||
| 3. | ALA650140 | F | The compound was tested for the concentration to inhibit 50% of B16 murine melanoma cells. | Mus musculus | 12 | cell-based format | Scientific Literature | ||
| 4. | ALA665027 | F | Tested for the DNA unwinding concentration that causes a shift of the topoisomers from the original to the middle position between the relaxed and the supercoiled bands. | 10 | assay format | Scientific Literature | |||
| 5. | ALA665630 | F | Inhibitory concentration against DU145 prostate cancer cell line | Homo sapiens | 4 | cell-based format | Scientific Literature | ||
| 6. | ALA669731 | B | Inhibition against decatenation activity of DNA topoisomerase II at a concentration of 3.2 uM | 1 | protein format | Scientific Literature | |||
| 7. | ALA668073 | F | The compound was tested for the concentration to inhibit 50% of DU-145 prostate cells. | Homo sapiens | 13 | cell-based format | Scientific Literature | ||
| 8. | ALA680234 | F | Inhibitory concentration against Granta lymphoma cancer cell line | Homo sapiens | 4 | cell-based format | Scientific Literature | ||
| 9. | ALA683154 | F | Inhibitory concentration against H522 (NSCLS) cancer cell line | Homo sapiens | 4 | cell-based format | Scientific Literature | ||
| 10. | ALA691415 | F | The compound was tested for the concentration to inhibit 50% of H226 non-small cell lung cells. | Homo sapiens | 13 | cell-based format | Scientific Literature | ||
| 11. | ALA690474 | F | Inhibitory concentration against HT-29 colon cancer cell line | Homo sapiens | 4 | cell-based format | Scientific Literature | ||
| 12. | ALA687736 | F | The compound was tested for the concentration to inhibit 50% of HT-29 colon cells. | Homo sapiens | 13 | cell-based format | Scientific Literature | ||
| 13. | ALA693205 | F | Inhibitory concentration against Hela cervix cancer cell line | Homo sapiens | 4 | cell-based format | Scientific Literature | ||
| 14. | ALA709724 | F | Inhibitory concentration against MCF-7 breast cancer cell line | Homo sapiens | 4 | cell-based format | Scientific Literature | ||
| 15. | ALA873875 | F | The compound was tested for the concentration to inhibit 50% of MDA-231 breast cancer cell lines. | Homo sapiens | 13 | cell-based format | Scientific Literature | ||
| 16. | ALA714145 | F | Inhibitory concentration against MIA PaCa pancreas cancer cell line | Homo sapiens | 4 | cell-based format | Scientific Literature | ||
| 17. | ALA771012 | F | The compound was tested for the concentration to inhibit 50% of Raji lymphoma cells. | Homo sapiens | 13 | cell-based format | Scientific Literature | ||
| 18. | ALA812287 | B | Inhibition of topoisomerase II as conversion of catenated to decatenated KDNA | Homo sapiens | 13 | protein format | Scientific Literature | ||
| 19. | ALA819258 | F | Inhibitory concentration against U937 lymphoma cancer cell line | Homo sapiens | 4 | cell-based format | Scientific Literature | ||
| 20. | ALA5225119 | B | Inhibition of human Top2 assessed as decrease in intensity of decatenated DNA using catenated KDNA at 0.5 to 10 uM | Homo sapiens | 1 | protein format | Scientific Literature |
The page will load shortly, Thanks for your patience!